Ignite Creation Date:
2025-12-24 @ 7:01 PM
Ignite Modification Date:
2025-12-29 @ 6:40 PM
Study NCT ID:
NCT00757757
Status:
TERMINATED
Last Update Posted:
2020-12-19
First Post:
2008-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-21
First Submit QC Date:
None
Study First Post Date:
2008-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-02-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL